Skip to main content

Announcements

Upcoming opportunities, insights, and programming from the Research Development Office are highlighted in the biweekly RD Newsletter and presented here in an expanded form. Sign up for the newsletter below or view past RD Newsletters at the bottom of this page.


Federal Funding Update

The Division of Research’s webpage (research.umd.edu/federalupdates) contains information, FAQs, and leadership guidance. 


 

REDCap Now Available at UMD!

The University of Maryland Baltimore’s Institute for Clinical & Translational Research (ICTR) is pleased to announce that REDCap (Research Electronic Data Capture) is now available to all faculty, staff, and students at the University of Maryland, College Park.


REDCap is a secure web application for building and managing online surveys and databases that allows for integration and interoperability of EHR, wearable technology data, scheduling and other facets of human subjects research through one interface at no cost to the researcher. This expanded access empowers the UMD community to easily collect and manage data securely, engage in multi-site collaboration, and export data to common statistical packages, with support provided by the UMB REDCap team. 

Learn more here or contact the REDCap team at redcap@umaryland.edu


Events

Bio/MedTech Customer Discovery Cohort

The NSF I-Corps Mid-Atlantic Hub is hosting a special Bio/MedTech customer discovery cohort.  The program is open to  research- and academic-based teams and entrepreneurs who are interested in commercializing Bio/MedTech innovations. The cohort will integrate industry-specific guidance and expertise with traditional NSF I-Corps training. All sessions except for the networking showcase are virtual and in eastern time. 
 

Session 1:  September 12 → 8:30-11:30 a.m.

Session 2:  September 19 → 8:30-11:30 a.m.

Session 3:  September 26, Bio/MedTech Networking Showcase (in-person, at The LaunchPort) → 9:30-11:30 a.m.

Session 4:  October 3 → 8:30-11:30 a.m.


On the Horizon

Trailblazer Award for New and Early-Stage Investigators (R21 Clinical Trial Optional)

Forecast, estimated publication around Nov 21, 2025

The NIH Trailblazer Award is a new funding opportunity for early-stage investigators. The goal is to support research that integrates engineering and physical sciences with life and biomedical sciences. Investigators with backgrounds in fields like physics, mathematics, chemistry, and computer science should consider applying. The Trailblazer Award will support a variety of projects, including high-risk, high-impact research and those focused on technology design, discovery, or hypothesis testing. This advance notice is to allow potential applicants time to prepare their proposals and form collaborations.
 

 


Newsletter Archive

Foundations Bulletin Archive

Back to Top